An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery
Status:
Withdrawn
Trial end date:
2017-07-27
Target enrollment:
Participant gender:
Summary
The purpose of this study will be to evaluate a standardized, evidence-based protocol versus
a conventional approach for the dosing of oxytocin in vaginal delivery.
Phase:
Phase 4
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health